DiscoverThis Week in Addiction Medicine from ASAMLead: Injectable-Only Overlapping Buprenorphine Starting Protocol in a Low-Threshold Setting
Lead: Injectable-Only Overlapping Buprenorphine Starting Protocol in a Low-Threshold Setting

Lead: Injectable-Only Overlapping Buprenorphine Starting Protocol in a Low-Threshold Setting

Update: 2025-08-26
Share

Description

Injectable-Only Overlapping Buprenorphine Starting Protocol in a Low-Threshold Setting 


JAMA Network Open 


Injectable-only buprenorphine protocols are an exciting new strategy for buprenorphine initiation, particularly in the fentanyl era. This is a cohort study of 95 patients with moderate to severe opioid use disorder who received care in a low-threshold setting in Seattle. 79% of patients included in the study were experiencing homelessness or living in permanent supportive housing. Patients selected a long-acting injectable (LAI) buprenorphine initiation protocol which included three escalating doses of LAI buprenorphine over three days, with no sublingual buprenorphine and without cessation of fentanyl/opioid use. 75% of the patients completed the protocol, and 64% received a second monthly dose of LAI buprenorphine.


 


Read this issue of the ASAM Weekly


Subscribe to the ASAM Weekly


Visit ASAM

Comments 
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Lead: Injectable-Only Overlapping Buprenorphine Starting Protocol in a Low-Threshold Setting

Lead: Injectable-Only Overlapping Buprenorphine Starting Protocol in a Low-Threshold Setting

American Society of Addiction Medicine